CSIMarket
 
Harvard Bioscience Inc   (NASDAQ: HBIO)
 

Harvard Bioscience Inc's Customers Performance

HBIO



 
HBIO's Source of Revenues During the corresponding time, Harvard Bioscience Inc recorded a revenue increase by 16.35 % year on year, sequentially revenue grew by 12.27 %. While revenue at the Harvard Bioscience Inc 's corporate clients

List of HBIO Customers




for the same period Harvard Bioscience Inc recorded revenue increase by 16.35 % year on year, sequentially revenue grew by 12.27 %.

List of HBIO Customers

Harvard Bioscience Inc's Business Units
Instruments Equipment Software and Accessories    84.96 % of total Revenue
Service Maintenance and Warranty Contracts    20.29 % of total Revenue
Asia Other    7.59 % of total Revenue
EMEA    25.89 % of total Revenue
CHINA    14.57 % of total Revenue
Single Reporting Segment    191.32 % of total Revenue






Harvard Bioscience Inc's Comment on Sales, Marketing and Customers



The company's CMT product line serves academic and government laboratories, biotechnology and pharmaceutical companies, and contract research organizations (CROs). The Preclinical product line is primarily marketed to pharmaceutical and biotechnology companies, CROs, and larger academic laboratories. The CMT products support academic research and early-stage drug discovery, offering instruments such as electroporation devices, amino acid analyzers, spectrophotometers, precision pumps, electrophysiology equipment, and the MeshMEA™ system for organoid research. The Preclinical products facilitate research from basic science through drug discovery and development, including telemetry systems, behavioral and surgical tools, respiratory system solutions, and inhalation and exposure systems. Customers and markets referenced in company filings include Biochrom, BTX, Buxco, DSI, Harvard Apparatus, HEKA, Hugo Sachs, KD Scientific, MCS, Panlab, and Warner.





Harvard Bioscience Inc’s Comment on Sales, Marketing and Customers


The company's CMT product line serves academic and government laboratories, biotechnology and pharmaceutical companies, and contract research organizations (CROs). The Preclinical product line is primarily marketed to pharmaceutical and biotechnology companies, CROs, and larger academic laboratories. The CMT products support academic research and early-stage drug discovery, offering instruments such as electroporation devices, amino acid analyzers, spectrophotometers, precision pumps, electrophysiology equipment, and the MeshMEA™ system for organoid research. The Preclinical products facilitate research from basic science through drug discovery and development, including telemetry systems, behavioral and surgical tools, respiratory system solutions, and inhalation and exposure systems. Customers and markets referenced in company filings include Biochrom, BTX, Buxco, DSI, Harvard Apparatus, HEKA, Hugo Sachs, KD Scientific, MCS, Panlab, and Warner.








HBIO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Harvard Bioscience Inc 35.98 88.16 -10.41 339
SUBTOTAL 0.00 0.00 0.00 -

Sources: Harvard Bioscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Harvard Bioscience Inc’s corporate clients.
For your research, we’ve provided 9 tables on Harvard Bioscience Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.